Lake Street Maintains Stereotaxis(STXS.US) With Buy Rating, Maintains Target Price $4
Lake Street Keeps Their Buy Rating on Stereotaxis (STXS)
A Quick Look at Today's Ratings for Stereotaxis(STXS.US), With a Forecast Between $4 to $5
A Quick Look at Today's Ratings for Stereotaxis(STXS.US), With a Forecast Between $4 to $5
Piper Sandler Sticks to Their Buy Rating for Stereotaxis (STXS)
Analysts Are Bullish on Top Healthcare Stocks: Stereotaxis (STXS), Neumora Therapeutics, Inc. (NMRA)
Analysts' Top Healthcare Picks: Stereotaxis (STXS), Capricor Therapeutics (CAPR)
Analysts Are Bullish on Top Healthcare Stocks: Joint (JYNT), Stereotaxis (STXS)
Lake Street Keeps Their Buy Rating on Stereotaxis (STXS)
Stereotaxis Set for Breakout Growth: Buy Rating Affirmed Amidst Regulatory Advances and Robust Financials
Stereotaxis Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Stereotaxis (STXS), LifeMD (LFMD)
Stereotaxis (STXS) Gets a Buy From Lake Street
Lake Street Keeps Their Buy Rating on Stereotaxis (STXS)
Roth MKM Initiates Coverage On Stereotaxis With Buy Rating, Announces Price Target of $5
Stereotaxis Analyst Ratings
Stereotaxis's Growth Trajectory: A Buy Rating With a Focus on Innovation and Expanding Markets
Stereotaxis (STXS) Gets a Buy From Craig-Hallum
Craig-Hallum Keeps Their Buy Rating on Stereotaxis (STXS)
Analysts' Top Healthcare Picks: Aura Biosciences Inc (AURA), Stereotaxis (STXS)
No Data